HIGHLIGHTS
- who: Ewa Marcinkowska from the Department of Biotechnology, University of Wroclaw, Joliot-Curie, a, Wroclaw, Poland have published the research: Vitamin D Derivatives in Acute Myeloid Leukemia: The Matter of Selecting the Right Targets, in the Journal: Nutrients 2022, 14, 2851. of /2022/
- what: The aim in the treatment of AML is an elimination of leukemic blasts. The lessons learnt from ATRA therapies prompted studies focused on identification of AML subtypes sensitive and resistant to 1,25D-induced differentiation.
- how: AML it is necessary to define the subtypes of the disease which are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.